University of Akron Research Foundation, 21MedTech ink landmark licensing agreement

Story excerpt provided by Cleveland Plain Dealer.

Written by Jennifer Conn.

AKRON, Ohio – In one of the most significant licensing arrangements by The University of Akron in its 148-year history, medical company 21MedTech has exclusively licensed two polymer technologies developed for regenerative medicine and 3D printing by the University of Akron Research Foundation.

UA Professor Matthew Becker, a scholar and innovator in organic polymer chemistry and biomaterials, developed the technologies. Becker is the university’s W. Gerald Austen Endowed Chair of Polymer Science and Polymer Engineering.

“It’s particularly rewarding to see the translation of our fundamental research into therapies and devices designed to help people in such a vast number of indications,” Becker said in a news release. “These are disruptive technologies and we are pleased to be working with the medical device and pharmaceutical veterans at 21MedTech.”

Click here to read the complete article.

Originally published January 31, 2018.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: